Clinical Trials Browser

Phase 2 × Ovarian Neoplasms × Irinotecan × Clear all

NCT01091259 2015-11-24

Irinotecan and Bevacizumab for Recurrent Ovarian Cancer

Phase 2 Completed

29 enrolled 11 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00003345 2013-06-21

Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer

Phase 2 Completed

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms